Results 21 to 30 of about 3,216,819 (320)
Journal of Orofacial Sciences, 2017 The ability of immune system to detect and destroy the altered/abnormal cells may inhibit the development of various cancers. The immune system had been proposed as a tactic in sustaining nonneoplastic state and also for the development of immunotherapy ...
Sri Lalitha Kaja +5 more
doaj +2 more sources
Exosome-mediated regulation of tumor immunology. [PDF]
Cancer Sci, 2018 Exosomes are representative extracellular vesicles (EV) derived from multivesicular endosomes (MVE) and have been described as new particles in the communication of neighborhood and/or distant cells by serving as vehicles for transfer between cells of ...
Seo N, Akiyoshi K, Shiku H.
europepmc +2 more sources
CA: A Cancer Journal for Clinicians, 1975 Charles F. McKhann, Melvin A. Yarlott
openalex +4 more sources
Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy. [PDF]
Crit Rev Immunol, 2019 Communication between the nervous and immune systems is required for the body to regulate physiological homeostasis. Beta-adrenergic receptors expressed on immune cells mediate the modulation of immune response by neural activity.
Wang W, Cao X.
europepmc +2 more sources
Resident memory T cells, critical components in tumor immunology. [PDF]
J Immunother Cancer, 2018 CD8+ T lymphocytes are the major anti-tumor effector cells. Most cancer immunotherapeutic approaches seek to amplify cytotoxic T lymphocytes (CTL) specific to malignant cells.
Mami-Chouaib F +7 more
europepmc +2 more sources
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer. [PDF]
Int J Mol Sci, 2018 Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted therapy have made only limited progress in recent years in improving the generally disappointing outcome.
Vrána D +8 more
europepmc +2 more sources
Tumor immunology CRISPR screening: present, past, and future. [PDF]
Trends Cancer, 2022 Dong MB +4 more
europepmc +2 more sources
Tumor immunology meets oncology (TIMO) XVII, April 20-22 2023 in Halle/Saale, Germany. [PDF]
Cancer Immunol Immunother, 2023 Seliger B.
europepmc +3 more sources
Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. [PDF]
J Transl Med, 2023 Li J, Wan C, Li X, Quan C, Li X, Wu X.
europepmc +3 more sources
Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy [PDF]
Frontiers in Oncology, 2022 Martina Seiffert +2 more
doaj +2 more sources